Heart transplantation was introduced as a clinical
procedure over 30 years ago. Since that time, the number of heart transplants
performed yearly in the United States has increased to an annual rate of well over 2,300.
The procedure is now widely recognized as an effective therapeutic option for the
treatment of end-stage heart disease.
Dr. Hillel Laks, an internationally renowned adult and pediatric cardiothoracic
surgeon, began UCLA's program in 1984. Since the inception of the program, over 1,440 patients have undergone this life-saving procedure. The development of effective
immunosuppressive drugs and the refinement of surgical procedures have led to remarkable
improvements in the long-term success of heart transplantation.